Nuermberger E - Search Results

1

In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.

Almeida D, Nuermberger E, Tyagi S, Bishai WR, Grosset J. Almeida D, et al. Among authors: nuermberger e. Antimicrob Agents Chemother. 2007 Dec;51(12):4261-6. doi: 10.1128/AAC.01123-07. Epub 2007 Oct 15. Antimicrob Agents Chemother. 2007. PMID: 17938193 Free PMC article.

2

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.

Yoshimatsu T, Nuermberger E, Tyagi S, Chaisson R, Bishai W, Grosset J. Yoshimatsu T, et al. Among authors: nuermberger e. Antimicrob Agents Chemother. 2002 Jun;46(6):1875-9. doi: 10.1128/AAC.46.6.1875-1879.2002. Antimicrob Agents Chemother. 2002. PMID: 12019103 Free PMC article.

3

Significance of macrolide resistance in Streptococcus pneumoniae.

Nuermberger EL, Bishai WR. Nuermberger EL, et al. J Antimicrob Chemother. 2003 Sep;52(3):524-5; author reply 525. doi: 10.1093/jac/dkg349. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888594 No abstract available.

4

Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.

Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Nuermberger EL, et al. Am J Respir Crit Care Med. 2004 Feb 1;169(3):421-6. doi: 10.1164/rccm.200310-1380OC. Epub 2003 Oct 24. Am J Respir Crit Care Med. 2004. PMID: 14578218

5

The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.

Nuermberger E, Bishai WR. Nuermberger E, et al. Clin Infect Dis. 2004 Jan 1;38(1):99-103. doi: 10.1086/380126. Epub 2003 Dec 8. Clin Infect Dis. 2004. PMID: 14679455 Review.

6

Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

Nuermberger EL, Yoshimatsu T, Tyagi S, Bishai WR, Grosset JH. Nuermberger EL, et al. Infect Immun. 2004 Feb;72(2):1065-71. doi: 10.1128/IAI.72.2.1065-1071.2004. Infect Immun. 2004. PMID: 14742554 Free PMC article.

7

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Nuermberger E, Grosset J. Nuermberger E, et al. Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):243-55. doi: 10.1007/s10096-004-1109-5. Epub 2004 Mar 13. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15024625 Review.

8

Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?

Nuermberger EL, Bishai WR. Nuermberger EL, et al. Clin Infect Dis. 2004 May 15;38 Suppl 4:S363-71. doi: 10.1086/382696. Clin Infect Dis. 2004. PMID: 15127371

9

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.

Nuermberger EL, Yoshimatsu T, Tyagi S, Williams K, Rosenthal I, O'Brien RJ, Vernon AA, Chaisson RE, Bishai WR, Grosset JH. Nuermberger EL, et al. Am J Respir Crit Care Med. 2004 Nov 15;170(10):1131-4. doi: 10.1164/rccm.200407-885OC. Epub 2004 Aug 11. Am J Respir Crit Care Med. 2004. PMID: 15306535

10

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.

Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, Grosset J, Bishai WR. Karakousis PC, et al. J Exp Med. 2004 Sep 6;200(5):647-57. doi: 10.1084/jem.20040646. J Exp Med. 2004. PMID: 15353557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters